Beckman Coulter's SARS-CoV-2 IgG antibody test receives FDA emergency use authorization
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
Providing researchers with expanded capabilities in interrogating the tissue microenvironment
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019
Our new expert webinar series aims to help you get the most from your microbiology research
The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs
These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season
Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology
The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19
It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
llumina's COVIDSeq aims to generate information about the genomic sequence of the virus
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work
Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics
LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients
This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
Our expert webinar series aims to help you get the most from your drug discovery research
The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19
This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic